Browse > Article
http://dx.doi.org/10.3746/jkfn.2005.34.1.042

The Effects of Functional Tea (Mori Folium, Lycii Fructus, Chrysanthemi Flos, Zizyphi Fructus, Sesamum Semen, Raphani Semen) Supplement with Medical Nutrition Therapy on the Blood Lipid Levels and Antioxidant Status in Subjects with Hyperlipidemia  

Lim, Hyun-Jung (경희대학교 동서의학대학원 의학영양학과)
Cho, Kum-Ho (경희대학교 임상영양연구소)
Choue, Ryowon (경희대학교 동서의학대학원 의학영양학과, 경희대학교 임상영양연구소)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.34, no.1, 2005 , pp. 42-56 More about this Journal
Abstract
Hyperlipidemia is one of the risk factors for coronary artery disease. Despite of epidemiological evidence that tea consumption is associated with the reduced risk of coronary heart disease, experimental studies designed to show that drinking tea affects blood lipid concentration or oxidative stress have been unsuccessful. The purpose of this study was to investigate whether functional tea (three servings/day) supplement with medical nutrition therapy (MNT) lead to a beneficial outcomes in mildly hyperlipidemic adults. From February to October, 2003, the 43 hyperlipidemic (23 men, 20 women) subjects (total cholesterol$\geq$200 mg/dL or triglyceride$\geq$150 mg/dL) admitted to K Medical Center were studied. Subjects were randomly divided into 3 groups; placebo tea (PT), half dose of functional tea (HFT), full dose of functional tea (FFT). During 12 weeks of study period, the subjects were given placebo or functional tea daily with MNT. Anthropometric measurements, blood chemical analysis including lipid levels, total superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels, and dietary assessment were carried out at the beginning and end of experiment. The effects of functional tea were compared with the placebo in randomized clinical trial study. The placebo was prepared to match with the functional tea in color and taste. After the 12 weeks of MNT, the subjects had regular and balanced meal pattern. Consumption of foods high in cholesterol and saturated fat, salty foods, fried foods, and instant foods decreased significantly in all three groups (p<0.05). Intake of energy and cholesterol also decreased (p<0.05). Drinking three servings per day (390 mL/day) of functional tea significantly reduced the levels of blood triglyceride (HFT, 42.5%; FFT, 29.4%), total cholesterol (HFT, 8.5%; FFT, 13.7%), and atherogenic index (HFT, 14.6%; FFT, 21.7%). Whereas no changes were found in the LDL-, HDL-cholesterollevels, and LDL/HDL ratio. Plasma homocysteine (Hcy) concentration decreased significantly (p<0.05) in functional tea groups (HFT, 14.9%; FFT, 14.1%). SOD increased significantly (p<0.05) in HFT (8.3%). GSH-Px increased significantly (p<0.05) in FFT (12.8%). In conclusion, the MNT improved the dietary habits, in addition, functional tea supplement decreased blood lipid levels and Hcy, and increased SOD and GSH-Px levels. These results indicate that functional tea consumption may decrease the risk of cardiovascular disease via improving blood lipid levels and antioxidant status.
Keywords
functional tea; hyperlipidemia; antioxidant status; food habits; MNT;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Choi YS, Cho SH, Seo JM, Lee NH, Park WH, Song KE. 1999. Effectiveness of nutrition counseling on dietary behavior and serum levels of lipids and antioxidants in patients with cardiovascular disease. Korean J Nutrition 32: 681-690
2 Cho JH, Nam MS, Lee EJ, Oh SC, Kim KR, Lim SK, Lee HC, Huh KB, Lee SI, Lee KW. 1994. The level of serum total cholesterol and triglyceride in healthy Korean adults. Kor J Lipidol 4: 182-189
3 Yoo WS. 2000. The epidemiology of hyperlipidemia. In Diagnosis and treatment in hyperlipidemia. Association of hyperlipidemic therapy, Haneuyhak, Seoul. p 59
4 Hwang GH, Noh YH, Heo YR. 1999. A study on hyperlipidemia in Koreans-specially related to hematological characteristics and risk factors of hypercholesterolemia-. J Korean Soc Food Sci Nutr 28: 710-721
5 McPherson R, Spiller GA. 1996. Effects od dietary fatty acids and cholesterol on cardiovascular disease risk factors in man. In Handbook of lipids in human nutrition. Spiller GA, ed. CRC press, Inc., New York. p 41-49
6 Chung MH, Moon YH, Kim GW, Lee BJ. 1991. Effect of Cynanchi wilfordi Radix on experimentally induced hyperlimemia in rats. Kor J Pharmacogn 22: 66-67
7 Lee IY, Lee IH. 1998. Influence of cardiovascular risk factors on serum lipid levels and fatty acids composition in middle-aged men. Korean J Nutrition 31: 315-323
8 Summary Report of the Cause of Death Statistics. 2002. Korea National Statistical Office
9 Parks EJ. 2002. Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Br J Nutr 87: 247-253   DOI
10 Kim JS. 2000. The current status of Korean coronary heart disease. In Diagnosis and treatment in hyperlipidemia. Association of hyperlipidemic therapy, Haneuyhak, Seoul. p 64-74
11 Grundy SM, Denke MA. 1990. Dietary influence on serum lipids and lipoprotein. J Lipid Res 31: 1149-1172
12 Jeon KJ, Chung NS, Ahan SG, Ha JW, Lim SJ, Jang YS, Shim WH, Cho SY, Kim SS, Lee SH, Shin MJ. 1999. Studies on the efficacy and safety of Atorva-statin in hypercholesterolemic (LDL-cholesterol) patients. Korean Circulation J 29: 1309-1316   DOI
13 Barnard RJ, Faria DJ, Menges JE, Martin DA. 1993. Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats. Atherosclerosis 100: 229-236   DOI   ScienceOn
14 Garg A, Grundy SM, Koffler M. 1992. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM. Diabetes Care 15: 1572-1580   DOI   ScienceOn
15 Shin SH. 2000. The choice of medicine. In Diagnosis and treatment in hyperlipidemia. Association of hyperlipidemic therapy, Haneuyhak, Seoul. p 315-331
16 Insull W, Kafonek S, Golder D, Zieve F. 2001. Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin (10 mg) at six weeks. Am J Med 87: 554-559
17 Hirakawa Y, Shimokawa H. 2001. Lipid-lowering drugs. Nippon Yakurigaku Zasshi 118: 389-395   DOI   ScienceOn
18 Park JE, Kwon HC. 1995 Cardiovascular risk factors of Koreans. Kor J Lipidol 5: 97-102
19 Kim SJ, Choue RW, Yim JE, Kim YS. 1998. Effects of apo E polymorphisms and dietary counseling on the levels of plasma lipids in hyperlipidemic patients. Korean J Nutrition 31: 1411-1421
20 Park WH. 1996. A study on the effects of the Pungwidodamtang on high lipid diethyperlipidemia rats. Korean J Oriental Medical Pathology 10: 103-111
21 Ro HS, Ko WK, Kim OJ, Park KK, Cho YW, Park HS. 1996. Antihyperlipidemic activity of Scutellaris baicalensis Georg, Coptidis japonica Makino and Rhei koreanum Nakai on experimental hyperlipidemia in rats. J Kor Pharm Sci 26: 215-219
22 Choi MB, Kum SH. 1995. The effect of persicae semen on the hyperlipemia in rabbits. J Herbology 10: 1-11
23 Choi DG, Jung HJ, Chang YC, Kang SA, Ahn DK, Park SK. 2002. Effect of Dansamchunghyul-tang on hyperlipidemia on rat. Kor J Oriental Physiology & Pathology 16: 1138-1142
24 Kim NJ, Jung EA, Kim DH, Lee SI. 1999. Studies on development of antihyperlipidemic drugs from oriental herbal medicines-antihyperlipidemia activities of oriental herbal medicines-. Kor J Pharmacogn 30: 368-376
25 Chung MH, Han SJ. 1996. Effect of composite preparation of crude drugs on experimentally induced hyperlipidemia in rats-Sam whang sasim tang and Whang ryun haedok tang. Kor J Phar 27: 397-407
26 Ro HS, Ko WK, Park KK, Cho YH, Park HS. 1997. Antihyperlipidemic effects of Bupleuri radix, Paeoniae radix and Uncariae ramulus et Uncus on experimental hyperlipidemia in rats. J Appl Phamacol 5: 43-47
27 전국한의과대학심계내과학교실. 1995. 심계내과학. 서원당, 서울. p 212, 506
28 Committee for establishment of hyperlipidemia therapy guide. 1996. Guideline for hyperlipidemia therapy. 1st ed. p 35
29 Committee for establishment of hyperlipidemia therapy guide. 2003. Guideline for hyperlipidemia therapy. 2nd ed
30 Hatch FT. 1968. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1-68   DOI
31 Fletcher MJ. 1968. A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22: 393-397   DOI   ScienceOn
32 Burstein M, Scholnick HR, Morfin R. 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11: 583-595
33 Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
34 Yim JE, Choue RW, Kim YS, Oh SJ, Paeng JR. 2000. Dietary and simvastatin treatment on the blood lipid levels in the patients with hyperlipidemia according to genetic and biochemical markers. Kor J Lipidol 10: 215-229
35 Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169
36 Bartesaghi S, Accinni R, Leo GD, Cursano CF, Campolo J, Galluzzo C, Vegezzi PG, Parodi O. 2001. A new HPLC micromethod to measure total plasma homocysteine in newborn. J Pharm Biomed Anal 24: 1137-1141   DOI   ScienceOn
37 Arthur JR, Boyne R. 1985. Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci 36: 1569-1575   DOI   ScienceOn
38 McCord JM, Fridovich I. 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055
39 Yim JE, Choue RW, Kim SJ, Kim YS. 2000. Effects of nutrition therapy and drug treatment on the blood lipid levels in patients with hyperlipidemia according to genetic polymorphism of apo CIII. Korean J Nutrition 33: 813-823
40 Ministry of health & welfare. 2002. Report on 2001 National Health and Nutrition Survey. Seoul
41 Hegsted DM, McGandy RB, Myers ML, Stare FJ. 1965. Quantitatie effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 27: 281-295
42 Mensink RP. 1993. Effects of the individual saturated fatty acids on serum lipids and lipoprotein concentration. Am J Clin Nutr 57: 711s-714s
43 Mata P, Garrido JA, Blazquze E, Alverez-sala LA, Rubio MJ, Alonso R, Oya MD. 1992. Effects of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 56: 77-83
44 Kastin M, Clifton P, Bellin GB, Nestel PJ. 1990. n-3 fatty acids of marine origin lower systolic blood pressure and triglyceride but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Am J Clin Nutr 51: 1028- 1034
45 Schaefer EJ, Rees DG, Siguel EN. 1986. Nutrition, lipoproteins and atherosclerosis. Am J Clin Nutr 5: 99-111
46 Mattson FH, Erickson BA, Kligman AM. 1972. Effect of dietary cholesterol on serum cholesterol in man. Am J Clin Nutr 25: 589-594
47 Oh KW, Lee SI, Song KS, Nam CM, Kim YO, Lee YC. 1995. Fatty acid intake patterns and the relation of fatty acid intake to serum lipids of the Korean adults. Kor J Lipidol 5: 167-181
48 Kim MS, Choue RW, Chung SH, Koo SJ. 1998. Blood glucose lowering effects of mulberry leaves and silkworm extracts on mice fed with high-carbohydrate diet. Korean J Nutrition 31: 117-125
49 Lee HY, Kim SK. 1994. Effects fo nutritional status of Korean adults on lipid metabolism with age. Korean J Nutrition 27: 23-45
50 Hopkins PN. 1992. Effect of dietary cholesterol on serum cholesterol: a metaanalysis and review. Am J Clin Nutr 55: 1060-1070
51 Gotto AM. 1991. Cholesterol intake and serum cholesterol level. N Engl J Med 28: 912-913
52 Schomfeld G, Patsch W, Rudel LL, Nelson C, Epstein M, Oslon RE. 1982. Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J Clin Invest 69: 1072-1080   DOI
53 Connor WE, Connor SL. 1982. The dietary treatment of hyperlipidemia; Rationale, technique, and efficacy. Med Clinics North Am 66: 485-518   DOI
54 Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawker TR. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 62: 707-714   DOI   ScienceOn
55 Gotto AM. 1991. Cholesterol intake and serum cholesterol level. N Engl J Med 28: 912-913
56 Choi YS, Cho SH, Seo JM, Lee NH, Park WH, Song KE. 1999. Effectiveness of nutrition counseling on dietary behavior and serum levels of lipids and antioxidants in patients with cardiovascular disease. Korean J Nutrition 32: 681-690
57 Sikand G, Kashyap ML, Yang I. 1998. Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia. J Am Dietet Ass 98: 894-899
58 Chen F, Nakashima N, Kimura I, Kimura M, Asano N, Koya S. 1995. Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozotocin-diabetic mice. Biol Pharm Bull 18: 1676-1680   DOI   ScienceOn
59 The Korean Society of Circulation. 1995. Studies on the factors affecting blood lipids distribution in normal Korean. Korean Circulation J 25: 393-403   DOI
60 Cornwell PE, Morgan SL, Vaughn WH. 1993. Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromatogr 617: 136-139   DOI   ScienceOn
61 Kim HC. 2001. Textbook of herbal pharmacology. Jib mun dang press, Seoul. p 105-106
62 Youna WG, Kim NJ, Hong ND. 1994. Pharmacological effects of Lycium chinense. Kor J Pharmacogn 25: 264-271
63 신민교. 1991. 임상본초학. 영림출판사, 서울. p 169, 174, 254, 233, 518
64 顔正華 主編. 1991. 中藥學. 人民衛生出版社, 北京. p 65, 70, 160, 737, 760
65 Kim SY, Lee YC, Cho SY. 1999. Serum fatty acids in patients with angiographically-documented coronary artery disease. Korean J Nutrition 32: 166-174
66 Yamajaki K, Murata M. 1990. Frequency of atherogenic risk factors in Japanese obese children. Diabetes Res Clin Pract 10: s211-s219   DOI   ScienceOn
67 McCully KS. 1969. Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128
68 Welch GN, Loscalzo J. 1998. Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1050   DOI   ScienceOn
69 Malinow MR, Bostom AG, Krauss RM. 1999. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99: 178-182   DOI   ScienceOn
70 Yoo SK, Lee SJ. 2002. Effects of YK-209 mulberry leaves on antioxidative defense system of liver in streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr 31: 1065-1070   DOI   ScienceOn
71 Kim YH, Paik HY. 1994. Relationship between dietary fatty acids, plasma lipids, and fatty acid compositions of plasma and RBC in young Korean females. Korean J Nutrition 27: 109-117
72 Lee BK, Chang YK. 1999. Relationships between fatty acid intake and serum lipids in postmenopausal women. Korean J Nutrition 32: 437-447
73 Diehl HA. 1998. Coronary risk reduction through intensive community based lifestyle intervention: the coronary health improvement project (CHIP) experience. Am J Cardiol 82: 83T-87T   DOI   ScienceOn
74 Chen F, Nakashima N, Kimura I, Kimur M. 1995. Hypoglycemic activity and mechanism of extracts from mulberry leaves (Folium Mori) and cortex mori radicis in streptozotocin induced diabetic mice. Yakugaku Zasshi 115: 476-482   DOI
75 Kim KM, Jeong GS, Kim YG, Kwon JN. 2001. Effects of Whanggikyejiomul-tang on the hyperlipidemia in rats induced by triton WR-1339. Kor J Oriental Medical Physiology & Pathology 15: 531-536
76 Grundy SM, Ahrens EH Jr. 1970. The effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man. J Clin Invest 49: 1135-1152   DOI
77 Kraus RJ, Ganther HE. 1980. Reaction of cyanide with glutathione peroxidase. Biochem Biophys Res Commun 96: 1116-1122   DOI   ScienceOn
78 Watts GF, Lewis B, Brunt TNH, Lewis S, Coltart DJ, Smith DR, Mann JI, Swan AV. 1992. Effects on coronary artery desease of lipid lowering diet or diet plus cholestyramine. in the St. Thomas, Atherosclerosis Regression Study (STARS). Lancet 339: 563-569   DOI   ScienceOn